These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17593919)

  • 1. Anemia of chronic kidney disease: CHOIR and the FDA.
    Singh AK
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):406-7. PubMed ID: 17593919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements].
    Martín de Francisco AL; Aljama P; Arias M; Górriz JL; Martínez Castelao A; Portolés J
    Nefrologia; 2007; 27(4):399-404. PubMed ID: 17944575
    [No Abstract]   [Full Text] [Related]  

  • 3. Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
    Winkelmayer WC
    J Am Soc Nephrol; 2011 Jan; 22(1):1-2. PubMed ID: 21164031
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
    Singh AK
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):553-6. PubMed ID: 20203166
    [No Abstract]   [Full Text] [Related]  

  • 5. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
    KDOQI
    Am J Kidney Dis; 2007 Sep; 50(3):471-530. PubMed ID: 17720528
    [No Abstract]   [Full Text] [Related]  

  • 6. Debate: CON Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
    Locatelli F; Del Vecchio L
    Am J Nephrol; 2010; 31(6):557-60; discussion 561-2. PubMed ID: 20501989
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
    Parfrey PS
    Am J Nephrol; 2010; 31(6):565-6. PubMed ID: 20501992
    [No Abstract]   [Full Text] [Related]  

  • 8. Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
    Singh AK
    Am J Nephrol; 2010; 31(6):552-6; discussion 563-4. PubMed ID: 20501988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anemia and cardiovascular risk in the chronic kidney disease population--which hemoglobin target should be reached?].
    Krzesinski JM; Dubois B
    Rev Med Liege; 2007; 62(5-6):366-70. PubMed ID: 17725208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?
    Walker RG
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):935-7. PubMed ID: 18579671
    [No Abstract]   [Full Text] [Related]  

  • 12. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin levels, quality of life, and survival.
    Sadler JH; Meyer KB
    Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
    [No Abstract]   [Full Text] [Related]  

  • 14. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrogenic anemia and porphyrin biosynthesis].
    Ivanov E; Pisanets M
    Vutr Boles; 1983; 22(4):18-24. PubMed ID: 6675278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR).
    Kutner N
    Nephrol Dial Transplant; 2007 Jul; 22(7):2099. PubMed ID: 17395656
    [No Abstract]   [Full Text] [Related]  

  • 18. [There are no differences between non-diabetics and diabetics with respect to the effect of anaemia correction in chronic kidney disease].
    García López FJ
    Nefrologia; 2010; 30(2):258-9. PubMed ID: 20393624
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of haemolysis in the production of anaemia of chronic renal diseases.
    Joshi KC; Andleigh HS
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):149-53. PubMed ID: 5402624
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflict of interest in clinical guidelines should be avoided.
    Shaldon S
    Nephrol Dial Transplant; 2008 May; 23(5):1771; author reply 1772. PubMed ID: 18187498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.